[ Price : $8.95]
New York Attorney General Letitia James and a bipartisan coalition of 47 other attorneys general secure $17.85 million from drug m...[ Price : $8.95]
FDA accepts for review an Exelixis NDA for zanzalintinib in combination with the immune checkpoint inhibitor atezolizumab for pati...[ Price : $8.95]
FDA issues Pharming Group a complete response letter for its supplemental NDA seeking expanded approval of Joenja (leniolisib) for...[ Price : $8.95]
FDA discontinues the use of its Quality System Inspection Technique for medical device inspections and will instead conduct inspec...[ Price : $8.95]
Grail files the final module of its PMA for the companys multi-cancer early detection blood test.[ Price : $8.95]
FDA awards Biogen a breakthrough therapy designation for its experimental antibody litifilimab for treating cutaneous lupus erythe...[ Price : $8.95]
A group of Democratic senators ask HHS Office of Inspector General to clarify how it will oversee direct-to-consumer prescription ...[ Price : $8.95]
FDA releases a corrected version of a 12/30 Complete Response Letter issued to Corcept Therapeutics, indicating that the agency ha...